Recent Finacing
Recent Raise
RxCell develops iPSC-derived retinal photoreceptor and photoreceptor–RPE cell therapies for advanced photoreceptor loss, preparing IND and a Phase I/IIa trial for retinitis pigmentosa with academic collaborations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors